1. Home
  2. VHC vs ATYR Comparison

VHC vs ATYR Comparison

Compare VHC & ATYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VirnetX Holding Corp

VHC

VirnetX Holding Corp

N/A

Current Price

$20.41

Market Cap

79.2M

Sector

Miscellaneous

ML Signal

N/A

Logo aTyr Pharma Inc.

ATYR

aTyr Pharma Inc.

HOLD

Current Price

$0.67

Market Cap

69.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VHC
ATYR
Founded
2005
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Multi-Sector Companies
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
79.2M
69.2M
IPO Year
1999
2015

Fundamental Metrics

Financial Performance
Metric
VHC
ATYR
Price
$20.41
$0.67
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
$8.75
AVG Volume (30 Days)
32.5K
1.5M
Earning Date
03-16-2026
03-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$106,000.00
$190,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$18,728.88
P/E Ratio
N/A
N/A
Revenue Growth
2020.00
N/A
52 Week Low
$6.60
$0.64
52 Week High
$29.00
$7.29

Technical Indicators

Market Signals
Indicator
VHC
ATYR
Relative Strength Index (RSI) 50.05 38.65
Support Level $19.27 $0.69
Resistance Level $22.67 $0.76
Average True Range (ATR) 1.56 0.04
MACD 0.06 0.00
Stochastic Oscillator 40.62 14.40

Price Performance

Historical Comparison
VHC
ATYR

About VHC VirnetX Holding Corp

VirnetX Holding Corp is engaged in the business of commercializing a portfolio of patents. It is an Internet security software and technology company with patented technology for secure communications. The company's software and technology solutions, including its Secure Domain Name Registry and Technology, VirnetX One, War Room, VirnetX Matrix, and GABRIEL Connection Technology, are designed to be device and location-independent, and enable a secure real-time communication environment for all types of enterprise applications, services and critical infrastructures.

About ATYR aTyr Pharma Inc.

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.

Share on Social Networks: